Genprex, Inc. has entered into an agreement with institutional investors to issue and sell 7,425,744 common shares and warrants at a price of $1.01 per share, with a net proceed of around $6.7 million, which will be used for working capital and general corporate purposes. The offering is expected to close on or around July 21, 2023.